A study from FutureBrand found that the perception of pharma and healthcare companies improved since the beginning of the COVID-19 pandemic. Using data collected during lockdown, the 2020 FutureBrand Index found that pharma’s reputation has improved during the COVID-19 pandemic. The industry has been cast into the global spotlight over the past few months as
With double-digit pharma wins for the first time in the festival’s history, the industry validated its claim on the Cannes call for life-changing creativity. The big scorers that picked up Lions were Boehringer Ingelheim, Bayer, Takea, Eli Lilly, Biogen and Novartis in the U.S., while GlaxoSmithKline and AstraZeneca won for international work. Also worth a
The US’s Food and Drug Administration latest crackdown is targeting pharmacies selling illegal opioids online. The agency has issued warning letters this week to nine online pharmacies that run 53 websites selling drugs with suspect monikers like “Roxycodone” and “Tramadol Generic.” The majority of the websites were shut down a day later, aside from OneStopPharma.org—was
Another internet data scandal, Facebook and Cambridge Analytica, has consumers concerned about the safety of their personal information. Will people become more nervous about sharing their healthcare data in its wake? Probably not, stated several industry experts interviewed by FiercePharma, although pharma companies should still be aware of the controversy. Cambridge Analytica’s mishandling of data
